Glenmark Pharmaceuticals P/E Ratio

Current P/E Ratio
46.33
High Valuation
Very High - High growth expectations or significantly overvalued

Glenmark Pharmaceuticals (GLENMARK) P/E ratio is 46.33 (High), EPS (TTM) ₹48.26, current price ₹2192.00 on NSE vs historical average P/E of 22.92 (100.0th percentile) — Very High - High growth expectations or significantly overvalued. Read GLENMARK dividend history for the complete payout history and dividend yield track record.

Current Valuation Metrics

P/E Ratio 46.33
Current Price ₹2192.00
EPS (TTM) ₹48.26
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 22.92
Historical Range 10.2 - 42.78
Percentile 100.0%

Sector Context

Sector Average 55.69
Sector Median 31.4
Sector Rank #11 of 194
Sector Percentile 5.7%

Earnings Breakdown (TTM)

TTM EPS ₹34.13
Mar 2026 ₹10.68
Sept 2025 ₹21.63

GLENMARK P/E Ratio — Valuation Signal & Historical Context

Glenmark Pharmaceuticals P/E 46.33 vs historical average 22.92, range 10.2–42.78 — signal: Overvalued. For live price, revenue and the complete fundamental profile, see Glenmark Pharmaceuticals share price today.

  • Stock appears overvalued with PE of 46.33, suggesting caution for new investments
  • Current PE is 102.1% above historical average
  • Trading at discount to sector average PE of 55.69

Glenmark Pharmaceuticals P/E Ratio Historical Trend

GLENMARK annual price-to-earnings ratio — 8 years, EPS and year-end price. Current P/E 46.33 vs historical average 22.92. See Glenmark Pharmaceuticals P/B ratio trends to compare market price against book value per share.

GLENMARK Historical P/E Ratio — EPS, Year-End Price & Valuation

Glenmark Pharmaceuticals annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 42.78 37.74 ₹1614.50 NSE High
2022 16.82 31.22 ₹525.25 NSE Moderate
2021 13.91 36.14 ₹502.60 NSE Low
2020 10.2 33.9 ₹345.70 NSE Low
2019 27.23 25.42 ₹692.15 NSE High
2018 18.39 32.42 ₹596.10 NSE Moderate
2017 29.84 29.62 ₹884.00 NSE High
2016 24.21 38.15 ₹923.75 NSE Moderate

GLENMARK vs Healthcare Peers — P/E Ratio Comparison

Glenmark Pharmaceuticals P/E 46.33 vs Healthcare average 55.69, median 31.4 — range 2.86–916.67.

Sector Average
55.69
Sector Median
31.4
Lowest P/E
2.86
Highest P/E
916.67
Companies
194
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Murae Organisor MURAE 2.86 ₹41 Low
Phaarmasia PHRMASI 3.61 ₹64 Low
Sunrest Lifescience SUNREST 3.76 ₹30 Low
Sun Pharma Advanced Rese… SPARC 4.76 ₹7,399 Low
Shelter Pharma SHELTER 5.23 ₹47 Low
Dipna Pharmachem DPL 5.39 ₹14 Low
JFL Life Sciences JFLLIFE 5.41 ₹68 Low
Amwill Health Care AMWILL 7.26 ₹83 Low
Zenith Drugs ZENITHDRUG 7.69 ₹84 Low
Galaxy Medicare GML 7.8 ₹27 Low